Skip to main content

Table 1 Demographic characteristics – treated set

From: Efficacy and safety of iota-carrageenan nasal spray versus placebo in early treatment of the common cold in adults: the ICICC trial

 

I-C

Placebo

Total

Number of patients, N (%)

100 (100.0)

100 (100.0)

200 (100.0)

Sex, N (%)

   

 Male

40 (40.0)

38 (38.0)

78 (39.0)

 Female

60 (60.0)

62 (62.0)

122 (61.0)

Race, N (%)

   

 Asian

8 (8.0)

2 (2.0)

10 (5.0)

 Black or African American

2 (2.0)

1 (1.0)

3 (1.5)

 Hawaiian or Pacific Islander

0

1 (1.0)

1 (0.5)

 White

90 (90.0)

96 (96.0)

186 (93.0)

Age, mean (SD) [years]

20.01 (2.37)

19.93 (1.90)

19.97 (2.14)

BMI, mean (SD) [kg/m2]

23.98 (3.67)

23.66 (3.89)

23.82 (3.78)

Smoking history, N (%)

   

 Never smoked

80 (80.0)

83 (83.0)

163 (81.5)

 Ex-smoker

7 (7.0)

4 (4.0)

11 (5.5)

 Current smoker

13 (13.0)

13 (13.0)

26 (13.0)

Alcohol history, N (%)

   

 Does not drink

5 (5.0)

4 (4.0)

9 (4.5)

 No significant drinking

95 (95.0)

96 (96.0)

191 (95.5)

  1. BMI body mass index, SD standard deviation